Get started

Buysellsignal

OPGN Would you buy something that was 1000x more expensive? 6/9/2020 Alliance Global Partners Reiterated Rating to Buy and target price to $5.00 OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. Aug 11 Reuters: OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers Aug 9 Reuters: OpGen Co-Markets COVID-19 Antibody Test Kit. OpGen is marketing and promoting the CELLSEARCH system, CELLSEARCH CEC kit, and certain COVID-19 related products that are sold and distributed by MSB on a non-exclusive basis Market cap. 34.511M Net income: -12.446M Annual Sales $3.50 million If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
OLong
by TopgOptions
4
AMC ENTERTAINMENT HOLDINGS INC reversal signsAug 13 (Reuters) - AMC Entertainment Holdings Inc AMC : * AMC THEATRES® REOPENS ITS DOORS ON AUGUST 20 BY CELEBRATING 100 YEARS OF OPERATIONS WITH "MOVIES IN 2020 AT 1920 PRICES" * AMC ENTERTAINMENT HOLDINGS INC - WILL RESUME THEATRE OPERATIONS AT MORE THAN 100 U.S. LOCATIONS ON THURSDAY, AUGUST 20 * AMC ENTERTAINMENT - ALL U.S. THEATRE LOCATIONS TO OFFER ALL SEATS FOR ALL MOVIES AT 1920'S ADMISSION PRICE OF 15 CENTS EACH ON AUG 20 * AMC ENTERTAINMENT - CURRENTLY EXPECTS TO OPEN ABOUT TWO THIRDS OF ITS U.S. THEATRES IN TIME FOR SEPT 3 RELEASE OF WARNER BROS.' TENET Market cap. 580.486M Net Income -149.1M If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NYSE:AMCLong
by TopgOptions
ACHV Achieve Life Sciences 10X potential! Highest undervalued!On 8/7/2020 Brokerage LADENBURG THALM/SH SH Reiterated ACHV Rating to BUY and set the target price to $100.00, now the cost of one share is 9.84usd. You can find the asset on trading212, the most downloaded trading app in the U.K. With a market cap of $15.45 million and a worldwide working product, it`s hard to say ACHV can go lower than that. The only concern is how much upside potential does it have. On July 31 ACHIEVE ANNOUNCES PATENT GRANTED IN THE U.S. FOR NOVEL ANALOGS OF CYTISINICLINE FOR USE IN CNS AND ADDICTION INDICATIONS. Also Short Interest in Achieve Life Sciences Inc Drops By 81.1%. Achieve Life Sciences issued its quarterly earnings results on Aug 4th. The biopharmaceutical company reported ($1.68) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($3.80) by $2.12, Fidelity Earnings reports. If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:ACHVLong
by TopgOptions
2
BKYI Bio Key International huge upside potentialBIO-key, Provider of Multi-Factor Identity and Access Management Solutions, Hosts Q2 Investor Call Friday, Aug 14 at 10am ET. Innovative Credit Card Processor Clearent, LLC Switches to BIO-key’s PortalGuard Identity and Access Management Solution to Secure Customer Access and Deliver Secure Reset Capabilities. Source: yahoo finance The analysts are targeting a 2usd price per share. With a market cap of only 16.5 mil but also a debt of 14.5 mil, BKYI is one of the riskiest bets on the market with a huge potential though. The uprising volume is also a great sign. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:BKYILong
by TopgOptions
RMED RA Medical Systems Inc upside potentialRa Medical Systems, Inc. engages in the design, development, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. They have a debt of 56.957M, but also a small market cap of 11.314M. 6/12/2020 Richard Mejia Jr Director Buys 50,000 shares 5/29/2020 William R Enquist Director Buys 50,000 shares You can double your money quite fast. Not trading advice. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
RLong
by TopgOptions
BIOL Biolase upside potentialBIOLASE, Inc. is a medical device company, which engages in developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. MITCHELL KOPIN REPORTS 9.6% PASSIVE STAKE IN BIOLASE INC AS OF JULY 22 Armistice Capital Reports 9.99% Passive Stake In Biolase Inc As Of July 21 JACK W. SCHULER REPORTS A 20.54% STAKE IN BIOLASE INC AS OF JUNE 8, 2020 JACK W. SCHULER PREVIOUSLY HELD A 31.17% STAKE IN BIOLASE INC AS OF MAY 13, 2020 4/29/2020 Perkins Capital Management Inc. 1,381,000 $0.52M 0.6% +4.7% 4.373% 2/13/2020 Archon Capital Management LLC 2,675,427 $1.48M 0.3% +61.6% 8.645% You still have time to take this huge buying opportunity! Not trading advice. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
BLong
by TopgOptions
4
Would you buy this? ACHV Look at the volume!On July 31th : Achieve Life Sciences receives U.S. patent for its novel analogs of cytisinicline for use in prevention or treatment of CNS and addictive disorders. Aimed at regaining compliance with Nasdaq's $1 minimum bid price listing requirement, Achieve Life Sciences has executed a 1:20 reverse split of its common stock. Achieve Life Sciences is scheduled to be releasing its earnings data after the market closes on Thursday, August 6th. Analysts expect Achieve Life Sciences to post earnings of ($0.19) per share for the quarter. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:ACHVLong
by TopgOptions
2
Siemens Healthineers buys US cancer therapy company Varian $16BGermany-based Siemens Healthineers said Sunday it will buy U.S. cancer therapy and research company Varian in a deal worth around $16.4 billion. Siemens Healthineers SHL, -5.32%, in which industrial conglomerate Siemens holds a majority stake, said it will buy all shares in Varian Medical Systems, Inc. VAR, +3.18% for $177.50 per share in cash. It said that the acquisition is expected to close in the first half of 2021, and requires the approval of regulators and Varian shareholders. Varian’s board of directors unanimously approved the agreement, it added. Palo Alto, California-based Varian had revenues in the 2019 fiscal year of $3.2 billion, Siemens Healthineers said in a statement. Varian says it employs about 10,000 people around the world. Siemens Healthineers said it plans to finance the acquisition with a mix of debt and equity. Source: MarketWatch If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
VLong
by TopgOptions
B2GOLD CORP upside potentialB2Gold Corp. is an exploration company. The firm engages in the acquisition and development of mineral properties. B2GOLD REPORTS QUARTERLY GOLD PRODUCTION OF 241,593 OZ AND RECORD QUARTERLY REVENUE OF $442 M FOR Q2 2020; ON TRACK TO MEET ANNUAL PRODUCTION GUIDANCE OF 1,000,000 TO 1,055,000 OZ On 7/20/2020 Scotiabank Boosted Price Target to Outperform from $8.50 to $9.00 It`s in the overbought RSI area, we can expect a small bounce before another leg up. B2Gold pays an annual dividend of $0.08 per share, with a dividend yield of 1.16%. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
AMEX:BTGLong
by TopgOptions
RSR Reserve Rights Fib Retracement levels to watchRSR Reserve Rights have a dangerous low Circulating Supply of 6,849,999,000 RSR from a total supply of 100,000,000,000 RSR so do the math what will happen to the price when all the supply hits the market. For short term my target is at Fib 0.618 (7395 satoshi) for RSR, but in time can go even lower. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
RShort
by TopgOptions
8
WDI Wirecard insider buy? Why 68% in pre-exchange trading?!First of all Wirecard stock jumps up to 68 percent in pre-exchange trading at the beginning of the week. The reason for this is progress in the search for investors. According to insolvency administrator Michael Jaffé, 77 interested parties have signed confidentiality agreements for the core business: "We are confident that we will find an investor for the core business that offers significant entrepreneurial opportunities in an enormously growing market for an investor." Second, reports say that someone bought 1 mil euro worth of shares, maybe it was an insider buy who knows the deal Wirecard is about to make. In third place it`s Angela Merkel, the Chancellor of Germany who promoted Wirecard in China before the scandal, she somehow co-signed for Wirecard by doing that. I think the German government won`t let its people who put their lifetime savings in WDI stock to loose all the money. They also gave money to Lufthansa, they will need to buy part of Wirecard too. For sure they want a piece of that financial working business. Wirecard has Assets of 5.85Bil Euro and Liabilities of 3.93Bil, so a nice debt to assets of 67%. We will see a bounce sooner than expected. Not trading advice. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
WLong
by TopgOptions
FISV Fiserv Upside Potential 25% gainFiserv, Inc. engages in the provision of financial services technology. It operates through the Payments, Financial, and Corporate and Other segments. The Payments segment primarily provides electronic bill payment and presentment services, internet and mobile banking software and services, account-to-account transfers, person-to-person payment services, debit and credit card processing and services, payments infrastructure services, and other electronic payments software and services. The company is expected to report second-quarter earnings per share (EPS) of $0.93 and revenue of $3.32 billion on August 5. Goldman has a Conviction-Buy $125 price target on the company’s stock. Robert W. Baird Boost Price Target to Outperform targeting $134.00 ➝ $135.00 If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
FLong
by TopgOptions
CHEK Check-Cap upside potential - huge volume!Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening. Net Income $-13,840,000, but an encouraging Quick Ratio of 3.69. Looking at the volume, this asset can double its price is seconds. on 5/28/2020 HC Wainwright Reiterated Chek Rating to Buy and the target is $2.00. Not trading advice. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:CHEKLong
by TopgOptions
JAGX Would you buy something that was 10000x more expensive? Jaguar Health, Inc. is a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. July 20, 2020 : Jaguar Health, Inc. announced today that it has submitted to the U.S. Food and Drug Administration's Center for Veterinary Medicine the second-to-last required technical section to support approval of Jaguar's oral plant-based drug candidate Canalevia™ (crofelemer delayed-release tablets) to treat chemotherapy-induced diarrhea in dogs, although this filing was originally scheduled for submission by the end of August 2020. More than 230,000 dogs in the U.S. receive chemotherapy treatment for various cancers each year, and roughly one in four (more than 50,000 dogs) will experience diarrhea as a side effect of treatment. OASIS CAPITAL LLC REPORTS 9.99% PASSIVE STAKE IN JAGUAR HEALTH AS OF JULY 7- SEC FILING Net Income $-38,540,000 Market Cap $42.15 million Annual Sales $5.78 million Debt-to-Equity Ratio 0.08 JAGX is a risky bet that can double your money in seconds. Not trading advice. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:JAGXLong
by TopgOptions
5
RVVTF REVIVE THERAPEUTICS LTD upside potentialREVIVE THERAPEUTICS has a Market Capitalization of only 27.158M, while the Net Income (FY) reveals a debt, -1.028M. Some analists predict an Average Target Price of 2.36 usd. The indicators are bullish on most timeframes. Still a lot of room to grow, with that huge volume. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, like others, just leave me a P.M.
OTC:RVVTFLong
by TopgOptions
7
LIACF AMERICAN LITHIUM CORP upside potentialWith a MARKET CAP of only 140.29M and a Net Income of -9.289M and growing economic demand for lithium-based technologies makes American Lithium maybe worth a shot, especially compared to some other penny stocks out there. American Lithium Announces Maiden Pit-Constrained Mineral Resource of 5.37 Million Tonnes Lithium Carbonate Equivalent Measured and Indicated and 1.76 Million Tonnes Inferred. American Lithium Corp. is an exploration stage company. It is engaged in the acquisition, exploration, and development of lithium deposits. Looking at the charts, they show buy signals on most timeframes. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, like others, just leave me a P.M.
LLong
by TopgOptions
NKLA Nikola Corporation - the new Tesla? If the fuel of future cars will be hydrogen, then Nikola is already there, offering long miles hydrogen electric powertrains. Nikola Motor Company is a pioneer in electric heavy duty applications. Nikola offers both pure electric and also hydrogen electric powertrains. Nikola Badger EV pickup will debut at Nikola World 2020 in December offering 0-60 MPH in 2.9 Seconds and a Range of 600 Miles, 906 HP, 980 ft. lbs. of torque, 15 kilowatt power export with 220V and 110V. Even though the Market Capitalization of 19.575B is high, investors continue to bet on the growth potential of electric transportation. On 6/17/2020 Cowen brokerage Initiated Coverage to Outperform and put the target price at $79.00. The indicators show a buy signal on most of the timeframes. If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, like others, just leave me a P.M.
NASDAQ:NKLALong
by TopgOptions